Litcius/Paper detail

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

Marie Robin, Raphaël Porcher, Corentin Orvain, Jacques‐Olivier Bay, Fiorenza Barraco, Anne Huynh, A Charbonnier, Édouard Forcade, Sylvain Chantepie, Claude‐Eric Bulabois, Ibrahim Yakoub‐Agha, Marie Y. Detrait, David Michonneau, Pascal Turlure, Nicole Raus, Françoise Boyer, Felipe Suárez, Laure Vincent, Stéphanie N. Guyen, Jérôme Cornillon, Alban Villate, Brigitte Dupriez, Bruno Cassinat, Valérie Rolland, Marie Hélène Schlageter, Gèrard Socié, Jean‐Jacques Kiladjian

2021Bone Marrow Transplantation31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRuxolitinibTransplantationCumulative incidenceInternal medicineMyelofibrosisFludarabineHematopoietic stem cell transplantationSurgeryThymoglobulinGastroenterologyTacrolimusChemotherapyBone marrowCyclophosphamideMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesAcute Myeloid Leukemia Research
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups | Litcius